NCT01254097

Brief Summary

Antibiotics are lifesaving medicines and generally safe, yet unwanted side effects are common. While destroying illness-causing 'bad' bacteria, antibiotics can upset the protective 'good' bacteria in the body. This research will test if taking a probiotic with prescribed antibiotics will decrease the chance of having bothersome antibiotic-associated side effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 6, 2010

Completed
3 months until next milestone

Study Start

First participant enrolled

March 1, 2011

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
2.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

September 25, 2015

Status Verified

September 1, 2015

Enrollment Period

4 months

First QC Date

December 3, 2010

Last Update Submit

September 23, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of antibiotic associated diarrhea

    Groups will be compared based on rates of antibiotic associated diarrhea, symptoms developing in the two week window of when antibiotics are started.

    two weeks after start of antibiotics

Secondary Outcomes (1)

  • Participant knowledge of probiotics

    At participant recruitment

Study Arms (2)

Probiotic

PLACEBO COMPARATOR

Participants are provided in double blinded fashion, probiotic given to take with antibiotics prescribed by their provider.

Dietary Supplement: Probiotic

Placebo

PLACEBO COMPARATOR

Participants are provided in double blinded fashion, Look alike placebo given to take with antibiotics prescribed by their provider.

Dietary Supplement: Probiotic

Interventions

ProbioticDIETARY_SUPPLEMENT

Probiotic capsule, 2 capsules twice daily

Also known as: Florajen 3
PlaceboProbiotic

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults 18 - 79 years of age with infection requiring an oral antibiotic.
  • Must be able to be contacted via telephone.

You may not qualify if:

  • pregnancy,
  • breast-feeding,
  • those receiving tube feeding,
  • those with diarrhea as a current symptom of present illness, and pre-existing illnesses that contribute to diarrhea such as inflammatory bowel disease,
  • irritable bowel syndrome, colitis or celiac disease.
  • Those undergoing active cancer treatments with chemotherapeutic or radiation therapy,
  • immunocompromised persons,
  • history of cardiac valvular disease,
  • those taking a laxative or stool softener on a daily basis, as well as
  • persons treated with an antibiotic in the previous 60 days,
  • new antibiotic prescription that exceeds a 10 day course, or regular use of a probiotic within the previous three weeks (including daily ingestion of yogurt).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M.S. Hershey Medical Center, Dept of Family and Community Medicine

Hershey, Pennsylvania, 17033, United States

Location

MeSH Terms

Interventions

Probiotics

Intervention Hierarchy (Ancestors)

Dietary SupplementsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • William J Curry, MD, MS

    Milton S. Hershey Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Family and Community Medicine

Study Record Dates

First Submitted

December 3, 2010

First Posted

December 6, 2010

Study Start

March 1, 2011

Primary Completion

July 1, 2011

Study Completion

April 1, 2014

Last Updated

September 25, 2015

Record last verified: 2015-09

Locations